|
|
|
|
|
|
|
|
|
|
|
|
|
<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q/A
Amendment No. 1
[X] QUARTERLY REPORT PURSUANT TO SECTION 13
OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 1995
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13
OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from __________ to __________
Commission File NO. 0-15242
DURAMED PHARMACEUTICALS, INC.
State of Incorporation - Delaware
IRS Employer I.D. No. 11-2590026
7155 East Kemper Road
Cincinnati, Ohio 45249
(513) 731-9900
Indicate by checkmark whether the Registrant (1) has filed all reports required
to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934
during the preceding 12 months, and (2) has been subject to such filing
requirements for the past 90 days.
YES X NO
------ ------
Common Stock, $.01 par value per share:
Shares Outstanding as of June 30, 1995 8,046,743
Page 1 of 20 pages
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM FINANCIAL
STATEMENTS FOR THE QUARTERLY PERIOD ENDED JUNE 30, 1995 AND IS QUALIFIED IN ITS
ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-1995
<PERIOD-START> JAN-01-1995
<PERIOD-END> JUN-30-1995
<CASH> 2,600
<SECURITIES> 0
<RECEIVABLES> 6,885,076
<ALLOWANCES> 416,882
<INVENTORY> 11,097,166
<CURRENT-ASSETS> 21,180,828
<PP&E> 30,494,099
<DEPRECIATION> 10,782,310
<TOTAL-ASSETS> 44,011,552
<CURRENT-LIABILITIES> 20,993,411
<BONDS> 20,807,039
<COMMON> 80,467
0
75
<OTHER-SE> 644,114
<TOTAL-LIABILITY-AND-EQUITY> 44,011,552
<SALES> 25,614,394
<TOTAL-REVENUES> 25,614,394
<CGS> 14,717,951
<TOTAL-COSTS> 16,546,560
<OTHER-EXPENSES> 6,167,545
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 1,217,709
<INCOME-PRETAX> 1,682,580
<INCOME-TAX> 41,750
<INCOME-CONTINUING> 1,640,930
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 1,640,930
<EPS-PRIMARY> .15
<EPS-DILUTED> .15
</TABLE>
|
|